MeSH D002062 - bursitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| A.H. Robins Company | Cortisone | Cortisone |  | 1982-01-01 |  |  |
| Prednisone | Prednisone |  | 1982-01-01 |  |  | |
| AbbVie | Dexamethasone | Ozurdex | 2023-01-09 | 2009-06-17 | $492 M | Q4/23-Q3/24 |
| Alcon Research | Dexamethasone | Maxidex |  | 1982-01-01 |  |  |
| Dexamethasone, Neomycin, Polymyxin b | Neomycin Polymyxin B Sulfates Dexamethasone |  | 1986-11-17 |  |  | |
| Dexamethasone, Neomycin | Neomycin Sulfate-dexamethasone |  | 1986-07-21 |  |  | |
| Allergan | Dexamethasone | Aeroseb-dex |  | 1982-01-01 |  |  |
| Cortisone | Cortisone |  | 1982-01-01 |  |  | |
| Dexamethasone | Dexamethasone |  | 1982-01-01 |  |  | |
| Prednisone | Prednisone |  | 1982-01-01 |  |  | |
| Alpharma | Dexamethasone | Dexamethasone |  | 1986-10-10 |  |  |
1
2
3
4
5
6
...
15
>
Clinical Trials
Historical Success Rate
Phase 1
100%1/1
Phase 2
25%1/4
Phase 3
62%8/13
Approved: 8Overall Success rate: 15%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
...
10
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use